Top Biotech Companies (3,709)
Astera is a private foundation with a $2.5B endowment focused on steering science and technology toward an abundant future for all. They operate like a high-velocity startup, integrating neuroscience, AI, and bioengineering for AGI research.
A Cleveland-based pharmacy focused on improving medication adherence for patients with chronic conditions and on multiple medications
SOKOL GxP Services is a specialized firm providing Commissioning, Qualification, and Validation (CQV) services to the pharmaceutical, biotech, and cell therapy industries. They focus on quality-driven, agile, and lean operational support to ensure regulatory compliance and inspection readiness. Additionally, they operate the SOKOL GxP Academy, which provides training in GMP fundamentals and professional development to support the life sciences workforce.
Tackling a global health threat like antimicrobial resistance is not for the faint of heart, but the experienced and innovative team at Pattern Bioscience is on a mission to do it. Each year, drug-resistant bacterial infections claim more than a million lives globally and cost our healthcare system billions of dollars. Traditional diagnostic methods for bacterial infections remain rooted in...
Beeline Medicines is a clinical-stage biotechnology company focused on developing and delivering category-leading precision therapies for people living with autoimmune and inflammatory diseases. The company leverages a mechanistically-guided approach to target the underlying drivers of immune dysfunction, aiming to define new treatment paradigms and provide durable, life-changing impact for patients suffering from a broad array of devastating immune-mediated conditions to...
We help scientists solve disease and extend healthspan by building tools that simplify R&D, simulate biology, and untangle the complexity of life. Streamline computational analysis today. Simulate biology tomorrow.
Artos AI develops a generative-AI platform for biopharma and life-sciences organizations. Its software helps clinical development, medical writing, CMC, and regulatory teams create, manage, trace, and collaborate on documents used in regulatory submissions, including INDs, NDAs, and BLAs. By turning structured and unstructured data into submission-ready materials, Artos aims to shorten development timelines and bring treatments to patients faster and...
CCRM Nordic supports academic, small, and large industrial ATMP developers in translating research and early-stage clinical programs into treatments for patients, offering specialized expertise and facilities for the development, manufacturing, and commercialization of Advanced Therapy Medicinal Products.
Othram enables human identification from difficult evidence such as touch DNA, rootless hair, and decades-old bones. We specialize in "unsolvable" cold cases.
Ultima Genomics is unleashing the power of genomics at scale. Our mission is to continuously drive the scale of genomic information to enable unprecedented advances in biology and improvements in human health. With humanity on the cusp of a biological revolution, there is a virtually endless need for more genomic information to address biology’s complexity and dynamic change—and a further...
Westlake Chemical (NYSE: WLK) is a quality manufacturer and dependable global supplier of petrochemicals, plastics and building products. Our mission is to serve our clients by enhancing daily life through the products and services we provide, which in turn make life better for people every day. Employing approximately 9,500 people, Westlake operates from 36 locations in North America, 11 in Europe...
Westlake Chemical Corporation's Top Stability & Growth Strengths
Strong Market Position & Advantage: Westlake is widely viewed as a top‑tier PVC and chlor‑alkali producer with a leading LDPE footprint and strong North American building‑products platforms. Vertical integration from chlorine/EDC/VCM and PVC into downstream products supports cost position and market reach.
Diversified Revenue Streams: Two segments—Performance & Essential Materials and Housing & Infrastructure Products—span upstream chemicals through branded building products. HIP has been comparatively steadier than PEM, moderating overall cyclicality.
Future-Ready Strategy: Strategic acquisitions (Axiall, Hexion Epoxy, Boral/Westlake Royal, ACI) and sustainability offerings (e.g., GreenVin PVC, ISCC PLUS certification) broaden specialty exposure and align to evolving customer needs. Management is executing footprint optimization and a PEM profitability plan targeting improvement in 2026.
Legend Biotech is a global, commercial-stage biotechnology company developing and manufacturing novel therapies. We explore and apply innovative technologies to deliver cutting-edge options for patients around the world. Our corporate headquarters is located in Somerset, NJ, and our manufacturing footprint includes facilities in the United States, China and the Belgium.
Legend Biotech's Top Stability & Growth Strengths
Strong Market Position & Advantage: Carvykti is positioned as the first and only BCMA‑targeted therapy approved as early as second line in the U.S./EU with overall‑survival data reflected on label, and commercial uptake has outpaced Abecma in the BCMA CAR‑T segment. Market updates cite thousands of patients treated and describe the product as a current standard‑setter within BCMA CAR‑T for multiple myeloma.
Strong Revenue Growth: Revenue and CARVYKTI sales have scaled rapidly through 2024–2025, with FY2024 revenue roughly $627M (up sharply year over year) and CARVYKTI net trade sales around $963M in 2024 followed by sequential increases in 2025. Collaboration revenue tied to CARVYKTI also rose significantly as availability and demand expanded.
Strategic Partnerships: The J&J collaboration underpins global development and commercialization while additional manufacturing collaboration with Novartis and capacity build‑outs in Belgium and the U.S. support supply. A licensing deal with Novartis for a DLL3 CAR‑T program further validates the platform and broadens modality reach.
Atlanta Center for Reproductive Medicine (ACRM) is a state-of-the-art fertility center specializing in the diagnosis and treatment of infertility and reproductive endocrinology disorders. Founded in 1998, it is one of the largest centers in the metropolitan area, providing care in Advanced Reproductive Technologies (ART), including in-vitro fertilization (IVF), pre-genetic diagnosis (PGD), and egg recipiency, with a mission to help patients...
Basepair Inc. is a bioinformatics software company providing a cloud-based SaaS platform for analyzing, visualizing, and interpreting genomic and next-generation sequencing data. Its tools support genomics, transcriptomics, epigenetics, and multi-omics workflows for academic, commercial, and clinical research. The platform offers automated and custom pipelines, interactive visualization, secure storage, and deployment within customers’ cloud accounts, helping researchers accelerate analysis and improve...
Loyal is a clinical-stage veterinary biotechnology company dedicated to extending the healthy lifespan of dogs. The company develops pharmaceutical therapies and longevity drugs that target the underlying biological processes of aging to delay the onset of age-associated diseases and preserve quality of life for senior dogs, pioneering a new category of preventative veterinary prescription drugs.
Larimar Therapeutics is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases.
Epicrispr Biotechnologies is a biotechnology company developing ultracompact therapies to modulate gene expression in vivo using the smallest known Cas protein, CasMINI
Cytel enables decision-makers in the life sciences to unlock the full potential of their products. From navigating uncertainty to proving value, Cytel’s 30 years of global expertise in consulting, data-driven analytics, and industry-leading software helps biotech and pharmaceutical companies transform intelligence into confident decisions. We have an uncompromising commitment to scientific rigor and high standards of operational excellence, which are...
Cytel's Top Stability & Growth Strengths
Investor Backing & Capital Strength: Private-equity ownership by Astorg and Nordic Capital is positioned as support to accelerate Cytel’s next phase of growth and innovation, signaling access to growth-oriented capital and sponsorship.
Product Line Growth: East Horizon launched as a cloud-based evolution of Cytel’s trial-design software and has continued adding modules through 2025, indicating ongoing investment and expansion of the software offering.
Market Expansion: Multiple acquisitions in 2022–2023 (e.g., Stève Consultants and co.faktor) and an increase in offices from 2021 to 2023 indicate broader geographic coverage and capability expansion, particularly across Europe.
Xenon Pharmaceuticals is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. Our lead molecule, azetukalner, is a novel, potent, selective Kv7 potassium channel opener in Phase 3 clinical trials for the treatment of epilepsy, major depressive disorder (MDD) and bipolar depression (BPD). We are also advancing an early-stage portfolio...
